{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:19:11Z","timestamp":1773400751553,"version":"3.50.1"},"reference-count":73,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Status epilepticus (SE) is the most severe presentation of epilepsy. Currently, SE is defined according to 2 sequential time frames: time 1, after which it is unlikely that the seizure will resolve spontaneously, therefore requiring the initiation of therapy; and time 2, when long-term consequences become more likely. For convulsive SE, these time frames are well defined: 5\u2009minutes for time 1 and 30\u2009minutes for time 2. \u201cTime is brain\u201d in the treatment of SE, as delays in diagnosis and treatment are associated with worse outcomes. After clinical stabilization, the first step is the administration of intravenous (IV) benzodiazepines. Rapid initiation of treatment and use of appropriate dosing are more important than the selection of a specific benzodiazepine. Following this, treatment continues with the use of an IV antiseizure medication (ASM). In Brazil, the recommended options available are phenytoin and levetiracetam. Status epilepticus is considered refractory to treatment if seizures persist after the administration of benzodiazepines and IV ASM. The cornerstone of this stage is the induction of therapeutic coma using IV anesthetic drugs (IVADs), although evidence is limited regarding the choice among midazolam, propofol, or barbiturates. Super-refractory SE is defined when seizures persist despite continuous infusion of IVADs or recur after these drugs are tapered. There is very limited data regarding the treatment of super-refractory SE. In the absence of randomized controlled trials, treatment should be guided by the physician's experience, clinical judgment, and established therapeutic options from previous reports.<\/jats:p>","DOI":"10.1055\/s-0045-1801872","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T02:21:06Z","timestamp":1739326866000},"page":"001-010","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of convulsive status epilepticus in Brazil: a review"],"prefix":"10.1055","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4956-5542","authenticated-orcid":false,"given":"Luis Otavio","family":"Caboclo","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo SP, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"From the Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"issue":"01","key":"ref2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1528-1157.1970.tb03871.x","article-title":"Clinical and electroencephalographical classification of epileptic seizures","volume":"11","author":"H Gastaut","year":"1970","journal-title":"Epilepsia"},{"issue":"10","key":"ref3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"E Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"9531","key":"ref4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"R F Chin","year":"2006","journal-title":"Lancet"},{"issue":"05","key":"ref5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/epi.14729","article-title":"Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population-based study on German health insurance data","volume":"60","author":"S Schubert-Bast","year":"2019","journal-title":"Epilepsia"},{"issue":"01","key":"ref6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/epi.14607","article-title":"Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes","volume":"60","author":"M Leitinger","year":"2019","journal-title":"Epilepsia"},{"issue":"01","key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","article-title":"American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version","volume":"38","author":"L J Hirsch","year":"2021","journal-title":"J Clin Neurophysiol"},{"issue":"08","key":"ref8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/jcm5080071","article-title":"Status Epilepticus: Epidemiology and Public Health Needs","volume":"5","author":"S S\u00e1nchez","year":"2016","journal-title":"J Clin Med"},{"issue":"03","key":"ref9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/MEJ.0000000000000568","article-title":"Incidence, management and short-term prognosis of status epilepticus in the emergency department: a population survey","volume":"26","author":"P Nazerian","year":"2019","journal-title":"Eur J Emerg Med"},{"issue":"03","key":"ref10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ana.2541","article-title":"Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE)","volume":"85","author":"C Kellinghaus","year":"2019","journal-title":"Ann Neurol"},{"issue":"01","key":"ref11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"G M Brophy","year":"2012","journal-title":"Neurocrit Care"},{"issue":"01","key":"ref12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"T Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"issue":"03","key":"ref13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/epi.12017","article-title":"Cardiac injury in refractory status epilepticus","volume":"54","author":"S Hocker","year":"2013","journal-title":"Epilepsia"},{"issue":"12","key":"ref14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"D M Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"09","key":"ref15","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","article-title":"Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability","volume":"36","author":"R Kienitz","year":"2022","journal-title":"CNS Drugs"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1983.03330350028021","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"I E Leppik","year":"1983","journal-title":"JAMA"},{"issue":"07","key":"ref17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"R Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"issue":"02","key":"ref18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12028-024-01971-x","article-title":"Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review","volume":"41","author":"T D Dittrich","year":"2024","journal-title":"Neurocrit Care"},{"issue":"22","key":"ref19","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus","volume":"381","author":"J Kapur","year":"2019","journal-title":"N Engl J Med"},{"issue":"03","key":"ref20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/epi.16825","article-title":"Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial","volume":"62","author":"A G Sathe","year":"2021","journal-title":"Epilepsia"},{"issue":"03","key":"ref21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Z Yasiry","year":"2014","journal-title":"Seizure"},{"issue":"20","key":"ref22","doi-asserted-by":"publisher","first-page":"e2339","DOI":"10.1212\/WNL.0000000000007503","article-title":"Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus","volume":"92","author":"I S\u00e1nchez Fern\u00e1ndez","year":"2019","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"S R Dalziel","year":"2019","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"M D Lyttle","year":"2019","journal-title":"Lancet"},{"issue":"03","key":"ref25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/epi.17872","article-title":"Rapid administration of undiluted loading doses of levetiracetam","volume":"65","author":"S Martinez","year":"2024","journal-title":"Epilepsia"},{"issue":"07","key":"ref26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"S Ramael","year":"2006","journal-title":"Epilepsia"},{"issue":"08","key":"ref27","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/epi.16961","article-title":"Rapid administration of undiluted intravenous levetiracetam","volume":"62","author":"J T Haller","year":"2021","journal-title":"Epilepsia"},{"issue":"02","key":"ref28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1212\/wnl.38.2.202","article-title":"Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin","volume":"38","author":"D M Shaner","year":"1988","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"106466","DOI":"10.1016\/j.yebeh.2019.106466","article-title":"Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis","volume":"101","author":"F Brigo","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"03","key":"ref30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/epi.12058","article-title":"Lacosamide as a new treatment option in status epilepticus","volume":"54","author":"J H\u00f6fler","year":"2013","journal-title":"Epilepsia"},{"issue":"10","key":"ref31","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1111\/j.1528-1167.2011.03204.x","article-title":"Intravenous lacosamide in status epilepticus and seizure clusters","volume":"52","author":"J H\u00f6fler","year":"2011","journal-title":"Epilepsia"},{"issue":"02","key":"ref32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-0404.2010.01423.x","article-title":"Intravenous lacosamide for treatment of status epilepticus","volume":"123","author":"C Kellinghaus","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"06","key":"ref33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: Systematic review of current evidence","volume":"58","author":"A Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"issue":"06","key":"ref34","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ana.25249","article-title":"Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures","volume":"83","author":"A M Husain","year":"2018","journal-title":"Ann Neurol"},{"issue":"04","key":"ref35","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"L J Hirsch","year":"2018","journal-title":"Epilepsia"},{"issue":"04","key":"ref36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"M Holtkamp","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"S A Mayer","year":"2002","journal-title":"Arch Neurol"},{"issue":"02","key":"ref38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"J Novy","year":"2010","journal-title":"Epilepsia"},{"issue":"03","key":"ref39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/epi.12064","article-title":"Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study","volume":"54","author":"R Sutter","year":"2013","journal-title":"Epilepsia"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"S Shorvon","year":"2011","journal-title":"Brain"},{"issue":"05","key":"ref41","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamaneurol.2024.0108","article-title":"Treatment of Refractory Status Epilepticus With Continuous Intravenous Anesthetic Drugs: A Systematic Review","volume":"81","author":"Y K Au","year":"2024","journal-title":"JAMA Neurol"},{"issue":"02","key":"ref42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"J Claassen","year":"2002","journal-title":"Epilepsia"},{"issue":"04","key":"ref43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1212\/WNL.0000000000000054","article-title":"High-dose midazolam infusion for refractory status epilepticus","volume":"82","author":"A Fernandez","year":"2014","journal-title":"Neurology"},{"issue":"01","key":"ref44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1528-1157.1998.tb01269.x","article-title":"Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings","volume":"39","author":"M M Stecker","year":"1998","journal-title":"Epilepsia"},{"issue":"09","key":"ref45","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00134-003-1905-x","article-title":"The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome","volume":"29","author":"B Vasile","year":"2003","journal-title":"Intensive Care Med"},{"issue":"9250","key":"ref46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(00)03547-9","article-title":"Long-term propofol infusion and cardiac failure in adult head-injured patients","volume":"357","author":"O L Cremer","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"ref47","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1097\/CCM.0b013e3181b08ac7","article-title":"Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience","volume":"37","author":"V N Iyer","year":"2009","journal-title":"Crit Care Med"},{"issue":"01","key":"ref48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1212\/wnl.50.1.301","article-title":"Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children","volume":"50","author":"J P Hanna","year":"1998","journal-title":"Neurology"},{"issue":"03","key":"ref49","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1186\/cc13883","article-title":"Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study","volume":"18","author":"D Pugin","year":"2014","journal-title":"Crit Care"},{"issue":"11","key":"ref50","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s40263-018-0569-6","article-title":"Ketamine for Refractory Status Epilepticus: A Systematic Review","volume":"32","author":"A Rosati","year":"2018","journal-title":"CNS Drugs"},{"issue":"16","key":"ref51","doi-asserted-by":"publisher","first-page":"e2286","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus","volume":"95","author":"A Alkhachroum","year":"2020","journal-title":"Neurology"},{"issue":"08","key":"ref52","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"N Gaspard","year":"2013","journal-title":"Epilepsia"},{"issue":"07","key":"ref53","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1007\/s00415-024-12453-7","article-title":"The efficacy and safety of ketamine in the treatment of super-refractory status epilepticus: a systematic review","volume":"271","author":"M Yan","year":"2024","journal-title":"J Neurol"},{"issue":"08","key":"ref54","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/epi.18035","article-title":"A systematic review and meta-analysis of ketamine in pediatric status epilepticus","volume":"65","author":"N Chiriboga","year":"2024","journal-title":"Epilepsia"},{"issue":"03","key":"ref55","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s12028-023-01859-2","article-title":"A Comparison of Ketamine and Midazolam as First-Line Anesthetic Infusions for Pediatric Status Epilepticus","volume":"40","author":"M Jacobwitz","year":"2024","journal-title":"Neurocrit Care"},{"issue":"04","key":"ref56","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/epi.17550","article-title":"Ketamine as advanced second-line treatment in benzodiazepine-refractory convulsive status epilepticus in children","volume":"64","author":"S Buratti","year":"2023","journal-title":"Epilepsia"},{"issue":"08","key":"ref57","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1528-1157.1998.tb01177.x","article-title":"Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus","volume":"39","author":"R J DeLorenzo","year":"1998","journal-title":"Epilepsia"},{"issue":"03","key":"ref58","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"H Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"issue":"05","key":"ref59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/jcm5050054","article-title":"Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus","volume":"5","author":"M E Reznik","year":"2016","journal-title":"J Clin Med"},{"issue":"07","key":"ref60","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","article-title":"Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam","volume":"52","author":"V Alvarez","year":"2011","journal-title":"Epilepsia"},{"issue":"09","key":"ref61","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1097\/CCM.0b013e3182591ff1","article-title":"Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation","volume":"40","author":"R G Kowalski","year":"2012","journal-title":"Crit Care Med"},{"issue":"05","key":"ref62","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/CCM.0000000000000881","article-title":"Status epilepticus: impact of therapeutic coma on outcome","volume":"43","author":"N A Marchi","year":"2015","journal-title":"Crit Care Med"},{"issue":"08","key":"ref63","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","article-title":"Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study","volume":"82","author":"R Sutter","year":"2014","journal-title":"Neurology"},{"issue":"06","key":"ref64","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1212\/WNL.0000000000012292","article-title":"Safety and Efficacy of Coma Induction Following First-Line Treatment in Status Epilepticus: A 2-Center Study","volume":"97","author":"P De Stefano","year":"2021","journal-title":"Neurology"},{"issue":"05","key":"ref65","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/epi.14706","article-title":"Duration of therapeutic coma and outcome of refractory status epilepticus","volume":"60","author":"W G Muhlhofer","year":"2019","journal-title":"Epilepsia"},{"issue":"05","key":"ref66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee","volume":"20","author":"D G Vossler","year":"2020","journal-title":"Epilepsy Curr"},{"issue":"02","key":"ref67","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/CON.0000000000001103","article-title":"Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus","volume":"28","author":"E Trinka","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"01","key":"ref68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.09.003","article-title":"Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review","volume":"93","author":"A Neligan","year":"2011","journal-title":"Epilepsy Res"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/brain\/aws091","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"M Ferlisi","year":"2012","journal-title":"Brain"},{"issue":"08","key":"ref70","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/archneurol.2010.169","article-title":"Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review","volume":"67","author":"A Neligan","year":"2010","journal-title":"Arch Neurol"},{"issue":"06","key":"ref71","doi-asserted-by":"publisher","first-page":"1535759721999670","DOI":"10.1177\/1535759721999670","article-title":"Treatment of Super-Refractory Status Epilepticus: A Review","volume":"21","author":"J G Ochoa","year":"2021","journal-title":"Epilepsy Curr"},{"issue":"11","key":"ref72","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1111\/epi.17397","article-title":"International consensus recommendations for management of New Onset Refractory Status Epilepticus (NORSE) incl. Febrile Infection-Related Epilepsy Syndrome (FIRES): Statements and Supporting Evidence","volume":"63","author":"R Wickstrom","year":"2022","journal-title":"Epilepsia"},{"issue":"05","key":"ref73","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/epi.17933","article-title":"Second-line immunotherapy in new onset refractory status epilepticus","volume":"65","author":"A Hanin","year":"2024","journal-title":"Epilepsia"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1801872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T02:21:25Z","timestamp":1739326885000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1801872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":73,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2025,1,15]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["s00451801872"],"URL":"https:\/\/doi.org\/10.1055\/s-0045-1801872","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}